Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Gastroenterology|September 22, 2009
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitisWilliam J Sandborn, Jaroslaw Regula, Brian G Feagan, et al.
Lancet (London, England)|June 6, 2002
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialStephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, et al.
Gastroenterology|February 6, 2004
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's diseasePaul Rutgeerts, Brian G Feagan, Gary R Lichtenstein, et al.
Digestive Diseases and Sciences|February 8, 2012
Assessment of variables associated with smoking cessation in Crohn's diseaseYvette Leung, Gil G Kaplan, Kevin P Rioux, et al.
Annals of Internal Medicine|May 2, 2007
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trialWilliam J Sandborn, Paul Rutgeerts, Robert Enns, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 30, 2018
Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc AnalysisJean-Frédéric Colombel, Omoniyi J Adedokun, Christopher Gasink, et al.
Human Molecular Genetics|October 2, 2002
Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkageRichard H Duerr, M Michael Barmada, Leilei Zhang, et al.
European Urology|December 12, 2018
Inflammatory Bowel Disease and the Risk of Prostate CancerJacob A Burns, Adam B Weiner, William J Catalona, et al.
Sleep|November 2, 2011
Identification of causal genes, networks, and transcriptional regulators of REM sleep and wakeJoshua Millstein, Christopher J Winrow, Andrew Kasarskis, et al.
Pageof 23